Naidu L.P. – Trademark Portfolio

Entity Type: 13

Naidu L.P. holds 47 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 43 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 22 trademarks are registered. Notable registered marks include BONEO, EMMUNO, PORTIN, BIO-REP, and BIOQUAD. The owner is based in Pomona, CA.

981 Corporate Center Drive, Suite 120

Pomona, CA 91786

47 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (47 results)

Trademark Classifications

Naidu L.P.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (43 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Naidu L.P. have?

Naidu L.P. has 47 U.S. trademarks filed with the USPTO. Of these, 22 registered, 18 abandoned, 7 cancelled.

What trademark classes does Naidu L.P. file in?

Naidu L.P. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Naidu L.P.'s most well-known trademarks?

Naidu L.P.'s registered trademark portfolio includes well-known marks such as BONEO, EMMUNO, PORTIN, BIO-REP, and BIOQUAD. These are among 22 currently registered trademarks in the portfolio.

What is Naidu L.P.'s trademark registration success rate?

Naidu L.P. has a 47% trademark registration rate, with 22 out of 47 resolved applications resulting in successful registration. Currently, 0 applications are pending review.